The Current Ratio as of December 2025 (TTM) for Cara Therapeutics, Inc. (0HTC.L) is 3.48

According to Cara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.48. This represents a change of -72.71% compared to the average of 12.76 of the last 4 quarters.

Cara Therapeutics, Inc. (0HTC.L) Historical Current Ratio (quarterly & annually)

How has 0HTC.L Current Ratio performed in the past?

The mean historical Current Ratio of Cara Therapeutics, Inc. over the last ten years is 9.94. The current 3.48 Current Ratio has changed 3.40% with respect to the historical average. Over the past ten years (40 quarters), 0HTC.L's Current Ratio was at its highest in in the March 2025 quarter at 32.48. The Current Ratio was at its lowest in in the September 2024 quarter at 2.02.

Cara Therapeutics, Inc. (0HTC.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cara Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cara Therapeutics, Inc. (0HTC.L) Average Current Ratio

How has 0HTC.L Current Ratio performed in the past?

The current Current Ratio of Cara Therapeutics, Inc. (0HTC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cara Therapeutics, Inc. (0HTC.L) Current Ratio vs. Peers

How is 0HTC.L’s Current Ratio compared to its peers?

Cara Therapeutics, Inc.’s Current Ratio is less than VivoSim Labs, Inc. (4.52), greater than Imunon, Inc. (0), greater than Palatin Technologies, Inc. (1.02), greater than Unity Biotechnology, Inc. (1.95), greater than Endo International plc (3.10), greater than DMK Pharmaceuticals Corporation (0.81), greater than bluebird bio, Inc. (0.55), less than Zynerba Pharmaceuticals, Inc. (5.97), greater than Accelerate Diagnostics, Inc. (0.71), less than Invitae Corporation (6.41),

Build a custom stock screener for Cara Therapeutics, Inc. (0HTC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cara Therapeutics, Inc. (0HTC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.